Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Presenilin-1 | 39 | 2023 | 635 | 9.100 |
Why?
|
Alzheimer Disease | 75 | 2024 | 7975 | 8.060 |
Why?
|
CADASIL | 7 | 2022 | 78 | 2.740 |
Why?
|
Colombia | 19 | 2023 | 259 | 2.510 |
Why?
|
tau Proteins | 19 | 2023 | 1861 | 2.140 |
Why?
|
Amyloid beta-Peptides | 31 | 2023 | 3579 | 2.030 |
Why?
|
Neuropsychological Tests | 28 | 2024 | 6963 | 1.870 |
Why?
|
Amyloid | 8 | 2023 | 794 | 1.620 |
Why?
|
Heterozygote | 12 | 2023 | 2798 | 1.600 |
Why?
|
Memory Disorders | 6 | 2022 | 1183 | 1.490 |
Why?
|
Neurofilament Proteins | 2 | 2021 | 316 | 1.310 |
Why?
|
Positron-Emission Tomography | 30 | 2023 | 6361 | 1.290 |
Why?
|
Brain | 27 | 2023 | 26345 | 1.230 |
Why?
|
Apolipoprotein E3 | 5 | 2023 | 98 | 1.080 |
Why?
|
Mental Recall | 4 | 2020 | 1201 | 1.020 |
Why?
|
Evoked Potentials | 5 | 2018 | 1057 | 0.930 |
Why?
|
Mutation | 23 | 2024 | 29658 | 0.900 |
Why?
|
Dementia, Vascular | 2 | 2021 | 127 | 0.850 |
Why?
|
Tauopathies | 3 | 2023 | 306 | 0.840 |
Why?
|
Presenilins | 1 | 2021 | 54 | 0.790 |
Why?
|
Loneliness | 1 | 2022 | 181 | 0.750 |
Why?
|
Agnosia | 1 | 2020 | 66 | 0.740 |
Why?
|
Memory | 4 | 2020 | 2161 | 0.730 |
Why?
|
Cognition | 14 | 2023 | 6686 | 0.720 |
Why?
|
Olfaction Disorders | 1 | 2022 | 215 | 0.690 |
Why?
|
Memory, Short-Term | 3 | 2020 | 974 | 0.650 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 237 | 0.650 |
Why?
|
Magnetic Resonance Imaging | 26 | 2022 | 35326 | 0.610 |
Why?
|
Cross-Sectional Studies | 21 | 2023 | 24714 | 0.610 |
Why?
|
Semantics | 2 | 2020 | 583 | 0.600 |
Why?
|
Cognition Disorders | 6 | 2021 | 4026 | 0.580 |
Why?
|
Executive Function | 3 | 2020 | 1356 | 0.570 |
Why?
|
Neurodegenerative Diseases | 3 | 2020 | 1050 | 0.570 |
Why?
|
Dementia | 5 | 2022 | 2488 | 0.560 |
Why?
|
Peptide Fragments | 4 | 2019 | 5076 | 0.520 |
Why?
|
Humans | 98 | 2024 | 739398 | 0.500 |
Why?
|
Psychometrics | 2 | 2021 | 2995 | 0.470 |
Why?
|
Latin America | 5 | 2022 | 380 | 0.470 |
Why?
|
Reaction Time | 1 | 2020 | 2097 | 0.470 |
Why?
|
Corpus Striatum | 1 | 2019 | 1220 | 0.430 |
Why?
|
Adult | 39 | 2022 | 213394 | 0.420 |
Why?
|
Homozygote | 3 | 2022 | 1788 | 0.410 |
Why?
|
Aniline Compounds | 6 | 2021 | 990 | 0.400 |
Why?
|
Male | 52 | 2023 | 349022 | 0.390 |
Why?
|
Female | 50 | 2023 | 378853 | 0.370 |
Why?
|
Sex Characteristics | 2 | 2022 | 2583 | 0.370 |
Why?
|
Age of Onset | 5 | 2021 | 3263 | 0.360 |
Why?
|
Apolipoprotein E2 | 2 | 2020 | 127 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 7 | 2021 | 17384 | 0.340 |
Why?
|
Pandemics | 5 | 2022 | 8274 | 0.320 |
Why?
|
Verbal Behavior | 2 | 2012 | 339 | 0.300 |
Why?
|
Middle Aged | 29 | 2023 | 212863 | 0.280 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15036 | 0.280 |
Why?
|
Visual Perception | 1 | 2015 | 1418 | 0.270 |
Why?
|
Asymptomatic Diseases | 3 | 2019 | 549 | 0.270 |
Why?
|
Ethylene Glycols | 2 | 2019 | 156 | 0.260 |
Why?
|
Hippocampus | 4 | 2023 | 3657 | 0.260 |
Why?
|
Secondary Prevention | 1 | 2011 | 1516 | 0.260 |
Why?
|
Early Diagnosis | 4 | 2021 | 1186 | 0.250 |
Why?
|
Apolipoproteins E | 4 | 2023 | 1437 | 0.250 |
Why?
|
Apolipoprotein E4 | 3 | 2023 | 669 | 0.250 |
Why?
|
Longitudinal Studies | 8 | 2020 | 13880 | 0.250 |
Why?
|
Locus Coeruleus | 2 | 2022 | 179 | 0.240 |
Why?
|
Young Adult | 16 | 2022 | 56255 | 0.240 |
Why?
|
Retinal Artery | 2 | 2021 | 112 | 0.210 |
Why?
|
Amyloidogenic Proteins | 1 | 2022 | 151 | 0.210 |
Why?
|
Disease Progression | 5 | 2021 | 13237 | 0.200 |
Why?
|
Apolipoproteins | 1 | 2023 | 315 | 0.200 |
Why?
|
Personality Tests | 1 | 2021 | 83 | 0.200 |
Why?
|
Retinal Vein | 1 | 2021 | 47 | 0.190 |
Why?
|
Self Report | 3 | 2023 | 3524 | 0.180 |
Why?
|
Intermediate Filaments | 1 | 2020 | 173 | 0.180 |
Why?
|
Cohort Studies | 7 | 2021 | 40389 | 0.180 |
Why?
|
Aged | 21 | 2023 | 162698 | 0.180 |
Why?
|
Diffusion Tensor Imaging | 2 | 2021 | 2301 | 0.180 |
Why?
|
Independent Living | 2 | 2021 | 559 | 0.180 |
Why?
|
Spain | 1 | 2020 | 463 | 0.170 |
Why?
|
Genotype | 3 | 2023 | 12951 | 0.170 |
Why?
|
Ileum | 1 | 2021 | 563 | 0.160 |
Why?
|
Educational Status | 2 | 2023 | 2514 | 0.160 |
Why?
|
Botulinum Toxins, Type A | 1 | 2021 | 204 | 0.160 |
Why?
|
Cerebral Cortex | 2 | 2012 | 5721 | 0.160 |
Why?
|
Electroencephalography | 4 | 2019 | 6133 | 0.150 |
Why?
|
Receptors, Notch | 2 | 2020 | 737 | 0.150 |
Why?
|
Sex Factors | 2 | 2021 | 10398 | 0.150 |
Why?
|
Risk Reduction Behavior | 2 | 2021 | 1123 | 0.150 |
Why?
|
Urinary Incontinence | 1 | 2021 | 490 | 0.140 |
Why?
|
Photic Stimulation | 2 | 2015 | 2032 | 0.140 |
Why?
|
Carbolines | 1 | 2018 | 266 | 0.140 |
Why?
|
Thiazoles | 3 | 2018 | 1488 | 0.140 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 500 | 0.140 |
Why?
|
Adolescent | 8 | 2021 | 85405 | 0.130 |
Why?
|
Preventive Health Services | 1 | 2021 | 576 | 0.130 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 976 | 0.130 |
Why?
|
Brain Mapping | 4 | 2015 | 6666 | 0.130 |
Why?
|
Urinary Bladder | 1 | 2021 | 1153 | 0.130 |
Why?
|
Down Syndrome | 1 | 2023 | 873 | 0.120 |
Why?
|
Genes, Dominant | 2 | 2018 | 883 | 0.120 |
Why?
|
Atrophy | 2 | 2023 | 1571 | 0.120 |
Why?
|
Language | 1 | 2003 | 1447 | 0.120 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1129 | 0.110 |
Why?
|
Exercise Therapy | 1 | 2020 | 897 | 0.110 |
Why?
|
Child | 7 | 2021 | 77033 | 0.110 |
Why?
|
Pedigree | 2 | 2019 | 4640 | 0.110 |
Why?
|
Aged, 80 and over | 11 | 2023 | 57650 | 0.110 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19811 | 0.110 |
Why?
|
Cues | 1 | 2017 | 865 | 0.100 |
Why?
|
South America | 1 | 2011 | 181 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2019 | 2552 | 0.100 |
Why?
|
Discriminant Analysis | 1 | 2011 | 235 | 0.100 |
Why?
|
Boston | 2 | 2021 | 9314 | 0.100 |
Why?
|
Age Factors | 2 | 2018 | 18349 | 0.090 |
Why?
|
Organ Size | 1 | 2015 | 2247 | 0.090 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2018 | 1539 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2023 | 4463 | 0.090 |
Why?
|
Family | 1 | 2021 | 3141 | 0.090 |
Why?
|
Registries | 3 | 2020 | 8039 | 0.090 |
Why?
|
Psychomotor Performance | 1 | 2018 | 1899 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15500 | 0.090 |
Why?
|
Association Learning | 1 | 2010 | 224 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4211 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2019 | 2687 | 0.080 |
Why?
|
Life Style | 1 | 2020 | 3817 | 0.080 |
Why?
|
Aging | 2 | 2020 | 8613 | 0.080 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2623 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 2 | 2017 | 4035 | 0.080 |
Why?
|
Attention | 1 | 2018 | 2400 | 0.080 |
Why?
|
Socioeconomic Factors | 3 | 2020 | 7726 | 0.080 |
Why?
|
Risk Factors | 5 | 2022 | 71974 | 0.070 |
Why?
|
Plaque, Amyloid | 2 | 2021 | 728 | 0.070 |
Why?
|
Stroke | 2 | 2019 | 9898 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4182 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2881 | 0.070 |
Why?
|
Genetic Variation | 1 | 2020 | 6539 | 0.060 |
Why?
|
Chromosome Aberrations | 1 | 2011 | 1812 | 0.060 |
Why?
|
Mycophenolic Acid | 1 | 2007 | 338 | 0.060 |
Why?
|
Task Performance and Analysis | 1 | 2009 | 780 | 0.060 |
Why?
|
Intergenerational Relations | 1 | 2004 | 67 | 0.060 |
Why?
|
United States | 2 | 2022 | 69573 | 0.060 |
Why?
|
Walking | 2 | 2021 | 1177 | 0.060 |
Why?
|
Depression | 2 | 2023 | 7689 | 0.060 |
Why?
|
Functional Laterality | 1 | 2010 | 2291 | 0.060 |
Why?
|
Mice | 4 | 2023 | 81002 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3138 | 0.060 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2023 | 118 | 0.060 |
Why?
|
Pattern Recognition, Visual | 1 | 2009 | 824 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2011 | 6370 | 0.050 |
Why?
|
Phenotype | 4 | 2021 | 16301 | 0.050 |
Why?
|
Neuropsychology | 1 | 2022 | 109 | 0.050 |
Why?
|
Temporal Lobe | 1 | 2009 | 1671 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2021 | 76631 | 0.050 |
Why?
|
Animals | 6 | 2023 | 168368 | 0.050 |
Why?
|
Caribbean Region | 1 | 2021 | 194 | 0.050 |
Why?
|
Caudate Nucleus | 1 | 2002 | 394 | 0.050 |
Why?
|
Signal Transduction | 1 | 2023 | 23355 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2010 | 8977 | 0.040 |
Why?
|
Oxygen | 1 | 2010 | 4158 | 0.040 |
Why?
|
Fibrinogen | 1 | 2022 | 895 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15194 | 0.040 |
Why?
|
Urologic Surgical Procedures | 1 | 2021 | 277 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7275 | 0.040 |
Why?
|
Injections | 1 | 2021 | 837 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2004 | 3636 | 0.040 |
Why?
|
Ischemia | 1 | 2007 | 1908 | 0.040 |
Why?
|
Photography | 1 | 2021 | 518 | 0.040 |
Why?
|
Self Efficacy | 1 | 2021 | 607 | 0.040 |
Why?
|
Mental Status Schedule | 1 | 2017 | 321 | 0.040 |
Why?
|
Area Under Curve | 1 | 2020 | 1655 | 0.030 |
Why?
|
Endostatins | 1 | 2016 | 174 | 0.030 |
Why?
|
Reference Values | 2 | 2019 | 4983 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1248 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2500 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 2007 | 1941 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2023 | 1571 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4143 | 0.030 |
Why?
|
Drug Discovery | 1 | 2021 | 1056 | 0.030 |
Why?
|
Phosphorylation | 1 | 2023 | 8416 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2021 | 5058 | 0.030 |
Why?
|
Reoperation | 1 | 2021 | 4192 | 0.020 |
Why?
|
Kidney | 1 | 2007 | 7144 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1070 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2694 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2564 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2018 | 2303 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2016 | 1504 | 0.020 |
Why?
|
Fluorine Radioisotopes | 1 | 2012 | 447 | 0.020 |
Why?
|
Time Factors | 1 | 2011 | 40050 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2013 | 985 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 21694 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6942 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53037 | 0.020 |
Why?
|
Neural Pathways | 1 | 2018 | 2976 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6028 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5959 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7897 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9734 | 0.010 |
Why?
|
Sampling Studies | 1 | 2004 | 624 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10534 | 0.010 |
Why?
|
Biomedical Research | 1 | 2018 | 3301 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3584 | 0.010 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2004 | 303 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2002 | 635 | 0.010 |
Why?
|
Tobacco Use Disorder | 1 | 2004 | 682 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18003 | 0.010 |
Why?
|
Intelligence | 1 | 2002 | 919 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2007 | 8299 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 62693 | 0.010 |
Why?
|
Alcoholism | 1 | 2004 | 1892 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15070 | 0.010 |
Why?
|
Rats | 1 | 2007 | 24270 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10362 | 0.010 |
Why?
|
Concepts
(211)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(75)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_